SecBot SecBot
SECBOTREPLAY Home › Report › PHAT

PHAT · Frazier Life Sciences filed Amendment No

Phathom Pharmaceuticals, Inc. · SC 13D/A filed Nov 2, 2026 at 16:20 ET

At the news

NEUTRALIMPACT 3/10

SC 13D/A filed Nov 2, 2026 at 16:20 ET

Frazier Life Sciences filed Amendment No. 12 to its Schedule 13D for Phathom Pharmaceuticals, reporting aggregate beneficial ownership of approximately 12.5 million shares (about 15.4% of outstanding common stock, including warrants subject to beneficial ownership limitations). The filing is a routine periodic update with no change in purpose or demands; it reflects the group's ongoing passive investment and does not signal escalation or de-escalation.

  • Frazier Life Sciences Public Fund, L.P. directly holds 5,323,356 shares (6.5% of outstanding).
  • Frazier Life Sciences IX, L.P. directly holds 5,827,415 shares (7.2%).
  • Frazier Life Sciences XI, L.P. directly holds 980,286 shares (1.2%).
  • Frazier Life Sciences X, L.P. directly holds 59,403 shares (0.1%).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access